Not Just Another Creatine...It's "THE" Creatine!
This is the brand that started is all on June 4th, 2002 when Kre-Alkalyn® was awarded United States manufacturing patent #6,399,661.
Kre-Alkalyn® EFX is "buffered" creatine that does not convert into creatinine prior to reaching skeletal muscle tissue. It is packaged in a purple capsule that can be administered orally. Kre-Alkalyn® EFX is manufactured exclusively by All American Pharmaceutical Corporation.
HERE’S WHY KRE-ALKALYN EFX IS FORMULATED TO WIN:
The Kre-Alkalyn EFX Difference: It's Buffered. It's Stable. It Works!
From the Lab to the Gym!
Twenty-four elite athletes from the Bulgarian National Weightlifting Team† were selected to participate in a double-blind clinical study(1) comparing Kre-Alkalyn® to standard creatine monohydrate.
After 60 days, the Kre-Alkalyn® group (using 7.5 g per day) experienced an overall average strength increase of 28.25% above those in the unbuffered creatine monohydrate group!
†Elite athletes using 7.5 g of Kre-Alkalyn®. Individual results may vary. Referenced: (1) Stoychev K., Terziiski N. (2006). “Comparison of Kre-Alkalyn to Creatine…performance, & safety”.
For Best Results:
1.On Training Days...Take 1-2 capsules with pre and post workout meals.
2.On "Off" days...Take 1-2 capsules with breakfast.
3.Stick With The First and Original: Use Kre-Alkalyn® EFX!
Serving Size: 2 Capsules
Amount Per Serving % DV
Kre-Alkalyn® 1,500 mg
(buffered creatine monohydrate)
U.S. Patent #6,399,661
*Daily Value (DV) not established.
Customers who bought this product also commonly purchased the following combination of items.